SORTIS Invest Advised KDTB Research on the Fundraising for a New Antibiotic for Tuberculosis
KDTB Research, a drug development start-up developing a new medicine for treatment of Tuberculosis, closed a successful funding round with the assistance of SORTIS Invest. The financing was led by Innovation Capital – a venture capital fund located in Sofia, Bulgaria. KDTB Research is a company that specializes in developing superior drugs for treatment of […]
>> SORTIS Invest Advised KDTB Research on the Fundraising for a New Antibiotic for Tuberculosis